NHS England updates CDF List

NHS England has upded the Cancer Drugs Fund List on its website. We have updated our website to correspond.

Published

February 27, 2025

NHS England updates CDF List

NHS England has updated the Cancer Drugs Fund List. The latest version (v1.351) was uploaded to the NHS England Website on Wednesday 26, February 2025.

The following changes have been introduced:

Osimertinib (OSI3)

Osimertinib for adjuvant treatment in adults after complete tumour resection in patients with UICC/AJCC 8th edition stage IB or stage IIA or stage IIB or stage IIIA or N2 only stage IIIB non-small cell lung cancer whose tumours have either an EGFR exon 19 deletion or an exon 21 (L858R) substitution mutation where the following criteria have been met

Date moving into routine commissioning updated

Blinatumomab (BLI5)

Available to new patients column updated - see entry for more information